SCHEMBL19503879

SCHEMBL19503879

CCN(c1cc(Br)cc(C(=O)OC)c1)C1CCOCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EZH2 Q15910 9/20 0.44
▸ NOTUM Q6P988 1/20 0.43
▸ EED O75530 8/20 0.41
▸ RBBP4 Q09028 8/20 0.41
▸ SUZ12 Q15022 8/20 0.41
▸ AEBP2 Q6ZN18 8/20 0.41
▸ EZH1 Q92800 2/20 0.41
▸ PRMT5 O14744 1/20 0.39
▸ WDR77 Q9BQA1 1/20 0.39
▸ TUBB4A P04350 1/20 0.38
▸ TUBB P07437 1/20 0.38
▸ TUBA3C P0DPH7 1/20 0.38
▸ TUBA1B P68363 1/20 0.38
▸ TUBA4A P68366 1/20 0.38
▸ TUBB4B P68371 1/20 0.38
▸ TUBB3 Q13509 1/20 0.38
▸ TUBB2A Q13885 1/20 0.38
▸ TUBB8 Q3ZCM7 1/20 0.38
▸ TUBA3E Q6PEY2 1/20 0.38
▸ TUBA1A Q71U36 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19503760 0.86 EZH2 (0.44) EZH2EEDRBBP4SUZ12AEBP2
SCHEMBL29448162 0.78 EZH2 (0.59) EZH2EEDRBBP4SUZ12AEBP2
SCHEMBL13276957 0.78 EZH2 (0.59) EZH2EEDRBBP4SUZ12AEBP2
SCHEMBL16935216 0.77 EZH2 (0.49) EZH2EEDRBBP4SUZ12AEBP2
SCHEMBL19503759 0.76 EZH2 (0.37) EZH2EEDRBBP4SUZ12AEBP2
SCHEMBL24071426 0.74 NOTUM (0.47) EZH2NOTUMTUBB4ATUBBTUBA3C
SCHEMBL21839787 0.74 NOTUM (0.51) NOTUMTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL20317447 0.73 EZH2 (0.82) EZH2EEDRBBP4SUZ12AEBP2
SCHEMBL20503825 0.73 EED (0.61) EZH2EEDRBBP4SUZ12AEBP2
SCHEMBL19503754 0.72 EZH2 (0.56) EZH2EEDRBBP4SUZ12AEBP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116655612-A Synthetic method and application of EZH2 inhibitor 王亚男 2023-08-29 — — CN disclosed
WO-2017184999-A1 EZH2 INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-10-26 — — WO disclosed
Send feedback